{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:36:45Z","timestamp":1782938205339,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA246194"],"award-info":[{"award-number":["R21 CA246194"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["T32EY007157"],"award-info":[{"award-number":["T32EY007157"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","award":["T32GM152319"],"award-info":[{"award-number":["T32GM152319"]}],"id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI116730"],"award-info":[{"award-number":["R01AI116730"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI144264"],"award-info":[{"award-number":["R21AI144264"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK128463"],"award-info":[{"award-number":["R01DK128463"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","award":["VA BLRD I01 BX005941"],"award-info":[{"award-number":["VA BLRD I01 BX005941"]}],"id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006754","name":"Army Research Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xjidi.2026.100454","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:55:41Z","timestamp":1769705741000},"page":"100454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dissecting the role of imiquimod and isostearic acid in Aldara-induced psoriasis mouse model"],"prefix":"10.1016","volume":"6","author":[{"given":"Angela Rose","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia T.","family":"Gavalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Vadlakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-827X","authenticated-orcid":false,"given":"Parameswaran","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2026.100454_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621956","article-title":"Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies","volume":"12","author":"Bugaut","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.xjidi.2026.100454_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/kjm2.12683","article-title":"IL-23\/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1\/TRAF6\/TAK1\/NF-\u03baB pathway in macrophages and keratinocytes","volume":"39","author":"Chen","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.xjidi.2026.100454_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182022","article-title":"Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity","volume":"12","author":"Courbet","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xjidi.2026.100454_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100876","article-title":"NF-\u03baB c-Rel dictates the inflammatory threshold by acting as a transcriptional repressor","volume":"23","author":"de Jes\u00fas","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.xjidi.2026.100454_bib5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","article-title":"Toll-like receptor 7\/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects","volume":"141","author":"Garzorz-Stark","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100454_bib7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","article-title":"Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors","volume":"140","author":"Gilliet","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep20134","article-title":"Topical imiquimod yields systemic effects due to unintended oral uptake","volume":"6","author":"Grine","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.xjidi.2026.100454_bib9","doi-asserted-by":"crossref","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","article-title":"IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms","volume":"111","author":"Ha","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xjidi.2026.100454_bib10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib11","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1038\/s41598-019-39903-x","article-title":"Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice","volume":"9","author":"Horv\u00e1th","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.xjidi.2026.100454_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jdermsci.2016.07.007","article-title":"Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice","volume":"84","author":"Huang","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.xjidi.2026.100454_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.xjidi.2026.100454_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11095-009-9985-0","article-title":"Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship","volume":"27","author":"Ibrahim","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.xjidi.2026.100454_bib15","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/jid.2013.57","article-title":"A toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis","volume":"133","author":"Jiang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib16","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.1500194","article-title":"Identification of thiostrepton as a novel inhibitor for psoriasis-like inflammation induced by TLR7-9","volume":"195","author":"Lai","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.xjidi.2026.100454_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105452","article-title":"NF-\u03baB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasis","volume":"110","author":"Liu","year":"2024","journal-title":"EBiomedicine"},{"key":"10.1016\/j.xjidi.2026.100454_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.xjidi.2026.100454_bib19","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4049\/jimmunol.173.5.3051","article-title":"Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod","volume":"173","author":"Palamara","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.xjidi.2026.100454_bib20","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"28","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.xjidi.2026.100454_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13679-020-00380-3","article-title":"Deciphering the association between psoriasis and obesity: current evidence and treatment considerations","volume":"9","author":"Paroutoglou","year":"2020","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.xjidi.2026.100454_bib22","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.jid.5700286","article-title":"The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion","volume":"126","author":"Sch\u00f6n","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib23","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.201546263","article-title":"Free fatty acids sensitize dendritic cells to amplify TH1\/TH17-immune responses","volume":"46","author":"Stelzner","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xjidi.2026.100454_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10787-023-01175-3","article-title":"Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models","volume":"31","author":"Stra\u00df","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.xjidi.2026.100454_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.xjidi.2026.100454_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12367","article-title":"Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod","volume":"41","author":"Ueyama","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib27","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.xjidi.2026.100454_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bjd.13236","article-title":"Aldara\u00ae-induced skin inflammation: studies of patients with psoriasis","volume":"172","author":"Vinter","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib29","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100454_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-0960.2004.00030.x","article-title":"Psoriasis induced by topical imiquimod","volume":"45","author":"Wu","year":"2004","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100454_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","article-title":"Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.xjidi.2026.100454_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.15252\/emmm.201607027","article-title":"RIG-I antiviral signaling drives interleukin-23 production and psoriasis-like skin disease","volume":"9","author":"Zhu","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.xjidi.2026.100454_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114455","article-title":"Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis","volume":"14","author":"Zhu","year":"2022","journal-title":"EMBO Mol Med"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026726000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026726000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:12:49Z","timestamp":1779196369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026726000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2667026726000068"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100454","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissecting the role of imiquimod and isostearic acid in Aldara-induced psoriasis mouse model","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100454"}}